AAAAAA

   
Results: 1-13 |
Results: 13
Inhibition of insulin-like growth factor-I signaling by ethanol in neuronal cells
Authors: Hallak, H Seiler, AEM Green, JS Henderson, A Ross, BN Rubin, R
Citation: H. Hallak et al., Inhibition of insulin-like growth factor-I signaling by ethanol in neuronal cells, ALC CLIN EX, 25(7), 2001, pp. 1058-1064
Tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) by oxidant stress in cerebellar granule neurons: modulation by N-methyl-D-aspartate through calcineurin activity
Authors: Hallak, H Ramadan, B Rubin, R
Citation: H. Hallak et al., Tyrosine phosphorylation of insulin receptor substrate-1 (IRS-1) by oxidant stress in cerebellar granule neurons: modulation by N-methyl-D-aspartate through calcineurin activity, J NEUROCHEM, 77(1), 2001, pp. 63-70
Matrix metalloproteinase inhibition attenuates left ventricular remodelingand dysfunction in a rat model of progressive heart failure
Authors: Peterson, JT Hallak, H Johnson, L Li, H O'Brien, PM Sliskovic, DR Bocan, TMA Coker, ML Etoh, T Spinale, FG
Citation: Jt. Peterson et al., Matrix metalloproteinase inhibition attenuates left ventricular remodelingand dysfunction in a rat model of progressive heart failure, CIRCULATION, 103(18), 2001, pp. 2303-2309
Synchrotron X-ray diffraction evidence for native defects in the photovoltaic semiconductor CuInSe2
Authors: Kaplan, L Leitus, G Lyakhovitskaya, V Frolow, F Hallak, H Kvick, A Cahen, D
Citation: L. Kaplan et al., Synchrotron X-ray diffraction evidence for native defects in the photovoltaic semiconductor CuInSe2, ADVAN MATER, 12(5), 2000, pp. 366
Structure-activity relationships and pharmacokinetic analysis for a seriesof potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors
Authors: O'Brien, PM Ortwine, DF Pavlovsky, AG Picard, JA Sliskovic, DR Roth, BD Dyer, RD Johnson, LL Man, C Hallak, H
Citation: Pm. O'Brien et al., Structure-activity relationships and pharmacokinetic analysis for a seriesof potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitors, J MED CHEM, 43(2), 2000, pp. 156-166
Association of heterotrimeric G(i) with the insulin-like growth factor-I receptor - Release of G(beta gamma) subunits upon receptor activation
Authors: Hallak, H Seiler, AEM Green, JS Ross, BN Rubin, R
Citation: H. Hallak et al., Association of heterotrimeric G(i) with the insulin-like growth factor-I receptor - Release of G(beta gamma) subunits upon receptor activation, J BIOL CHEM, 275(4), 2000, pp. 2255-2258
Hypercholesterolemia causes mechanical weakening of rabbit atheroma - Local collagen loss as a prerequisite of plaque rupture
Authors: Rekhter, MD Hicks, GW Brammer, DW Hallak, H Kindt, E Chen, J Rosebury, WS Anderson, MK Kuipers, PJ Ryan, MJ
Citation: Md. Rekhter et al., Hypercholesterolemia causes mechanical weakening of rabbit atheroma - Local collagen loss as a prerequisite of plaque rupture, CIRCUL RES, 86(1), 2000, pp. 101-108
Quantitative method for biomarkers of collagen degradation using liquid chromatography tandem mass spectrometry
Authors: Kindt, E Rossi, DT Gueneva-Boucheva, K Hallak, H
Citation: E. Kindt et al., Quantitative method for biomarkers of collagen degradation using liquid chromatography tandem mass spectrometry, ANALYT BIOC, 283(1), 2000, pp. 71-76
Coronary arteriopathy in monkeys following administration of CI-1020, an endothelin A receptor antagonist
Authors: Albassam, MA Metz, AL Gragtmans, NJ King, LM Macallum, GE Hallak, H McGuire, EJ
Citation: Ma. Albassam et al., Coronary arteriopathy in monkeys following administration of CI-1020, an endothelin A receptor antagonist, TOX PATHOL, 27(2), 1999, pp. 156-164
Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow
Authors: Petrossian, E Parry, AJ Reddy, VM Akkersdijk, GP McMullan, DM Thompson, L Hendricks-Munoz, KD Hallak, H Hanley, FL Fineman, JR
Citation: E. Petrossian et al., Endothelin receptor blockade prevents the rise in pulmonary vascular resistance after cardiopulmonary bypass in lambs with increased pulmonary blood flow, J THOR SURG, 117(2), 1999, pp. 314-322
Angiotensin-converting enzyme and matrix metalloproteinase inhibition withdeveloping heart failure: Comparative effects on left ventricular functionand geometry
Authors: McElmurray, JH Mukherjee, R New, RB Sampson, AC King, MK Hendrick, JW Goldberg, A Peterson, TJ Hallak, H Zile, MR Spinale, FG
Citation: Jh. Mcelmurray et al., Angiotensin-converting enzyme and matrix metalloproteinase inhibition withdeveloping heart failure: Comparative effects on left ventricular functionand geometry, J PHARM EXP, 291(2), 1999, pp. 799-811
Nitric oxide induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase
Authors: Mohr, S Hallak, H de Boitte, A Lapetina, EG Brune, B
Citation: S. Mohr et al., Nitric oxide induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase, J BIOL CHEM, 274(14), 1999, pp. 9427-9430
Matrix metalloproteinase inhibition during the development of congestive heart failure - Effects on left ventricular dimensions and function
Authors: Spinale, FG Coker, ML Krombach, SR Mukherjee, R Hallak, H Houck, WV Clair, MJ Kribbs, SB Johnson, LL Peterson, JT Zile, MR
Citation: Fg. Spinale et al., Matrix metalloproteinase inhibition during the development of congestive heart failure - Effects on left ventricular dimensions and function, CIRCUL RES, 85(4), 1999, pp. 364-376
Risultati: 1-13 |